Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
1
Neutral
9
Bullish
4
Bearish
28
Neutral
13
Bullish
5
Bearish
27
Neutral
4
Bullish
1
Healthcare Services
Healthcare Service Provider
84 Cr
Moderate Risk
17.1
63.4
—
1.7
105.00
58.10
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Invicta Diagnostic Ltd (INVICTA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Invicta Diagnostic Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Invicta Diagnostic Ltd has traded between a low of ₹58.10 and a high of ₹105.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Invicta Diagnostic Ltd has a market capitalization of approximately 84.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Invicta Diagnostic Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.13 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 84.11 Cr, Invicta Diagnostic Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Invicta Diagnostic Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Invicta Diagnostic Ltd is 17.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
188.90 | 132 Cr | 60.91 | 5.14 | 0.00 | 5.87 | 8.80 | 3.00 | ||
75.25 | 131 Cr | 6.80 | 1.13 | 0.00 | 16.61 | 20.64 | 12.53 | ||
66.00 | 129 Cr | 25.68 | 2.46 | 0.00 | 9.53 | 9.10 | 0.00 | ||
68.50 | 103 Cr | 19.70 | 1.77 | 0.00 | 8.97 | 8.79 | 4.43 | ||
66.90 | 84 Cr | 17.13 | 1.68 | 0.00 | 9.83 | 13.44 | 8.08 | ||
20.48 | 36 Cr | 30.37 | 1.34 | 0.00 | 1.67 | 3.84 | 1.56 | ||
105.00 | 35 Cr | 18.23 | 1.05 | 3.33 | 5.17 | 6.31 | 5.44 | ||
| Median: 7 Co. | — | 68.50 | 103 Cr | 19.70 | 1.68 | 0.00 | 8.97 | 8.80 | 4.43 |
